Insulin Therapy Perspective

 
 
  • Where Is Insulin's Place in Treating Type 2 Diabetes? Should insulin be used for the treatment of type 2 diabetes mellitus? This study compares the safety of insulin therapy with other glucose-lowering regimens.
  • An Unusual Case of Type 1 Diabetes -- or Is It Type 2?   Dr. Anne Peters describes her management of a lean Asian man who came to her with a diagnosis of type 1 diabetes.
  • What's New in ADA's Latest Diabetes Guidelines?   Dr. Anne Peters discusses the changes to the standards of care updated annually by the American Diabetes Association.
  • CGM: Practical Uses in Diabetes   Dr. Anne Peters discusses the real-life use of continuous glucose monitoring and recent advances in the technology.
  • Treating Type 1 Diabetes With Stem Cells: A New Way Forward   Advances in technology have allowed for a new way to transplant stem cell-derived beta cells for the treatment of type 1 diabetes. How might this affect the future of clinical practice?
  • Insulin for Prediabetes?   Dr. Anne Peters describes her personalized approach to treating a patient with prediabetes, using clinical trial data and the patient's input to come up with an unusual plan.
  • Four Helpful Stroke Studies   A possible cause of transient global amnesia, a novel approach to CT scans, and other important data in stroke.
  • Glycemic Control, Cardiac Surgery, and Infection   Are there fewer post-op infections when glucose is normalized rapidly after cardiac surgery in children? William R. Jarvis, MD, comments on recent research.
  • Pregnancy and Diabetes: What Matters Most? Dr. Leszek Czupryniak talks with Dr. Maciej T. Malecki about the latest research on pregnancy in patients with diabetes.
  • Patient Ethnicity Alters A1c Goals   Dr. Bruce Wolffenbuttel talks with Dr. Leszek Czupryniak about new research that suggests that A1c goals should be different for patients of Asian, Hispanic, or Caucasian origin.
  • Why Is Hypoglycemia So Dangerous?   Dr. Brian Frier, an international expert on hypoglycemia, discusses the latest research with Dr. Leszek Czupryniak.
  • Glucose Control in Acute Events: Where Are We?   Dr. Peter Gaede talks with Dr. Leszek Czupryniak about the latest research on how tightly glucose levels should be controlled in diabetic patients suffering acute medical events.
  • Managing Diabetes 'As Complex as Bringing Up Children   Clinicians should study the new position statement on diabetes treatment to be able to make informed drug choices for individual patients, says Dr. David Matthews.
  • Novel Therapies for Diabetes on the Horizon   The EASD annual meeting revealed many advances in diabetes treatment, says Dr. Stefano del Prato, not only in terms of new drugs but also in identifying new targets for treatment.
  • EU Device Safety Lax, Clinicians Concerned   In the United States, the FDA regulates devices along with drugs, but Europe has no similar regulatory body for devices.
  • Why Should You Attend EASD 2012 in Berlin?   Dr. Leszek Czupryniak offers a preview of the upcoming meeting of the European Association for the Study of Diabetes, October 1-5 in Berlin, Germany
  • How to Use New Type 2 Diabetes Guidelines   Dr. Anne Peters, an author of the ADA/EASD guidance issued earlier this year, offers a step-by-step guide to selecting the right medications for patients with type 2 diabetes.
  • Nipping Prediabetes Reduces Risk for Disease Advancement New research suggests that diabetes prevention lies in a patient's ability to restore normal glucose regulation, even briefly.
  • ORIGIN's Good News, Bad News Will the results of the ORIGIN trial put to rest questions about the relationship between blood glucose and cardiovascular risk?
  • Bariatric Surgery's Benefits in Diabetes Management In 95% of the biliopancreatic diversion group, patients achieved complete remission of diabetes. How did those in other groups fare?
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.